SDDN 2025

Join InSphero at SDDN 2025!

We are excited to attend the SDDN 2025 meeting, and connect with researchers advancing innovative approaches in drug discovery. Don’t miss the opportunity to discuss the latest advancements in NAMs, and how physiologically relevant 3D in vitro models can strengthen translational confidence in early research.

The annual meeting for the Spanish Drug Discovery Network will take place from Wednesday, November 19th to Friday, November 21st in A Coruña, Spain. 

Meet our Team at SDDN 2025

Jan Lichtenberg

Jan Lichtenberg, PhD

CEO and Co-Founder

Scientific Talk at SDDN 2025

Scaling Complexity in 3D Microtissue Platforms: Advancing DILI Prediction and Immune–Islet Modeling

Date: Friday, November 21st, 2025 | 11:00 – 13:00  

Location: Attica Hotel, A Coruña, Spain 

Jan Lichtenberg

Jan Lichtenberg, PhD

CEO and Co-Founder

SDDN 2025 Resources

3D InSight™ Liver Microtissues as Promising Pre-clinical Safety Assessment In Vitro Tools: Mechanistic Investigation of Aflatoxin B1 Toxicity in Dog, Rat and Human
An integrative in silico toolbox for derisking drug-induced liver injury (DILI) liabilities
Enabling Early Safety Assessment with Low-Input RNA-Seq in Liver Microtissues Across Species and Compound Analogs
Non-Destructive Multiplexed Imaging of 3D Liver Microtissues for Multi-Modal DILI Assessment
3D InSight™ Predictive Liver Toxicology Services
3D InSight™ Liver Microtissues Applications
Liver Microtissues – A Highly Reproducible In Vitro Test System for Safety Assessment of Small Molecules
Leveraging Human, Animal Liver Microtissues and Low-Input RNA-Sequencing to Characterize Mechanisms of Drug-Induced Liver Injury

Your Success is Our Mission - Get in Touch

Fill in form below to contact our 3D in vitro experts

Sign up for our Newsletter

Get the latest news on 3D in vitro research

Webinar registration

Fill in the form below to register

View resource

Fill in the form below to view this resource